前沿探索融入严谨智造，中美史克天津工厂以近四十年品质坚守打造行业典范

Core Insights - The Chinese pharmaceutical and health industry is undergoing a significant structural adjustment driven by the "Healthy China 2030" strategy, shifting from basic availability of medicines to a focus on quality and safety [1] - Companies are increasingly prioritizing quality innovation and smart manufacturing as key competitive advantages in the evolving market landscape [1] Group 1: Company Overview - The Tianjin plant of China-Skyrise, wholly owned by Heliang, has been operating in China for nearly 40 years and emphasizes "rigorous manufacturing and quality commitment" as its development foundation [1] - The plant was the first to obtain national GMP certification in 1998 and has played a role in the quality upgrade of China's pharmaceutical industry [1] - The plant produces approximately 160 million boxes of well-known medicines annually, such as Fenbid and New Contac, reflecting a deep understanding of local health needs [1] Group 2: Technological Advancements - The plant is accelerating the layout of its smart manufacturing system with a focus on a "dual intelligence control" precision engineering system [4] - An investment is planned for a smart workshop dedicated to Fenbid production, featuring top-tier international production lines and real-time monitoring systems to enhance product consistency and stability [4] - The plant's modern laboratory platform supports product quality and original research manufacturing, enabling the completion of numerous process optimization projects each year [5] Group 3: Research and Development - Original research technology is a core competitive advantage for the Tianjin plant, which has successfully localized the production of original drugs [6] - The plant has made significant breakthroughs in core pharmaceutical technologies, such as membrane-controlled sustained-release technology for New Contac and multi-layer sustained-release for Fenbid [8] Group 4: Sustainability Initiatives - The Tianjin plant integrates green manufacturing and sustainable development into its strategic operations, optimizing energy structures and implementing effective measures for emissions reduction [9] - The plant utilizes 100% green electricity in its operations and has established a distributed outdoor photovoltaic project with a capacity of 1,120.56 kW [9] - The plant has received greenhouse gas carbon neutrality certificates since 2022 and is set to obtain national green factory certification in 2024, showcasing its commitment to environmental protection [12]